{
  "directed": true,
  "graph": {
    "annotation_list": {},
    "annotation_pattern": {
      "Species": "^\\d+$"
    },
    "annotation_url": {
      "Confidence": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/confidence/confidence-1.0.0.belanno",
      "Gender": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/gender/gender-1.0.0.belanno",
      "MeSHAnatomy": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-anatomy/mesh-anatomy-20170511.belanno"
    },
    "document_metadata": {
      "authors": "Yojana Gadiya",
      "contact": "charles.hoyt@scai.fraunhofer.de",
      "copyright": "Copyright Â© 2019 Fraunhofer Institute SCAI, All rights reserved.",
      "description": "",
      "licenses": "CC BY 4.0",
      "name": "Pharmacological inhibition of HDAC6 reverses cognitive impairment and tau pathology as a result of cisplatin treatment.",
      "version": "1.0.0"
    },
    "namespace_pattern": {
      "PUBCHEM": "^\\d+$"
    },
    "namespace_url": {
      "CHEBI": "https://raw.githubusercontent.com/pharmacome/conso/c328ad964c08967a0417a887510b97b965a62fa5/external/chebi-names.belns",
      "EFO": "https://raw.githubusercontent.com/pharmacome/conso/5d2c2ea6f7112421cc8089a3f021a75ab60bb373/external/efo-names.belns",
      "GO": "https://raw.githubusercontent.com/pharmacome/conso/d9d270e11aac480542c412d4222983a5f042b8ae/external/go-names.belns",
      "HGNC": "https://raw.githubusercontent.com/pharmacome/conso/c328ad964c08967a0417a887510b97b965a62fa5/external/hgnc-names.belns",
      "INTERPRO": "https://raw.githubusercontent.com/pharmacome/conso/c328ad964c08967a0417a887510b97b965a62fa5/external/interpro-names.belns",
      "MESH": "https://raw.githubusercontent.com/pharmacome/conso/f02c6ad4a4791a8ed45448513b9de8c8f1b00c87/external/mesh-names.belns"
    },
    "path": "hdac6/ma2018.bel",
    "pybel_version": "0.14.10"
  },
  "links": [
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Gender": {
          "Male": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Heijnen CJ",
          "Huo X",
          "Jarpe MB",
          "Kavelaars A",
          "Ma J"
        ],
        "date": "2018-10-01",
        "db": "PubMed",
        "db_id": "30270813",
        "db_name": "Pharmacological inhibition of HDAC6 reverses cognitive impairment and tau pathology as a result of cisplatin treatment.",
        "first": "Ma J",
        "journal": "Acta neuropathologica communications",
        "last": "Heijnen CJ",
        "pages": "103",
        "volume": "6"
      },
      "evidence": "The cumulative dose of cisplatin has been shown to effectively control tumor growth in mice [47].",
      "key": "09437d24c20cf50c8a9e7387f61102f5",
      "line": 85,
      "relation": "negativeCorrelation",
      "source": 0,
      "target": 18
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Gender": {
          "Male": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Heijnen CJ",
          "Huo X",
          "Jarpe MB",
          "Kavelaars A",
          "Ma J"
        ],
        "date": "2018-10-01",
        "db": "PubMed",
        "db_id": "30270813",
        "db_name": "Pharmacological inhibition of HDAC6 reverses cognitive impairment and tau pathology as a result of cisplatin treatment.",
        "first": "Ma J",
        "journal": "Acta neuropathologica communications",
        "last": "Heijnen CJ",
        "pages": "103",
        "volume": "6"
      },
      "evidence": "Cisplatin-treated mice showed an impaired performance in the Y maze test, as evidenced by a reduction in the rate of perfect alternations (Fig. 1b), implying a decreased spatial working memory function (post-hoc test, p = 0.0086).",
      "key": "d4cf8d87c722ab8cdd9b5fe93160042c",
      "line": 94,
      "relation": "decreases",
      "source": 0,
      "target": 22
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Gender": {
          "Male": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Heijnen CJ",
          "Huo X",
          "Jarpe MB",
          "Kavelaars A",
          "Ma J"
        ],
        "date": "2018-10-01",
        "db": "PubMed",
        "db_id": "30270813",
        "db_name": "Pharmacological inhibition of HDAC6 reverses cognitive impairment and tau pathology as a result of cisplatin treatment.",
        "first": "Ma J",
        "journal": "Acta neuropathologica communications",
        "last": "Heijnen CJ",
        "pages": "103",
        "volume": "6"
      },
      "evidence": "Taken together, these findings indicate that cisplatin impaired spatial working memory, executive functioning, and problem-solving abilities in mice and, more importantly, that the brain-penetrating HDAC6 inhibitor ACY-1083 reversed these deficits.",
      "key": "58839be4885f7d7da51b6ae0a8876194",
      "line": 146,
      "relation": "decreases",
      "source": 0,
      "target": 22
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Gender": {
          "Male": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Heijnen CJ",
          "Huo X",
          "Jarpe MB",
          "Kavelaars A",
          "Ma J"
        ],
        "date": "2018-10-01",
        "db": "PubMed",
        "db_id": "30270813",
        "db_name": "Pharmacological inhibition of HDAC6 reverses cognitive impairment and tau pathology as a result of cisplatin treatment.",
        "first": "Ma J",
        "journal": "Acta neuropathologica communications",
        "last": "Heijnen CJ",
        "pages": "103",
        "volume": "6"
      },
      "evidence": "Of note, we showed previously that ACY-1083 and ACY-1215 are equally effective in reversing cisplatin-induced peripheral neuropathy [31].",
      "key": "c9cb2e9a0cf82d690a0680504d16c051",
      "line": 114,
      "relation": "increases",
      "source": 0,
      "target": 17
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Gender": {
          "Male": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Heijnen CJ",
          "Huo X",
          "Jarpe MB",
          "Kavelaars A",
          "Ma J"
        ],
        "date": "2018-10-01",
        "db": "PubMed",
        "db_id": "30270813",
        "db_name": "Pharmacological inhibition of HDAC6 reverses cognitive impairment and tau pathology as a result of cisplatin treatment.",
        "first": "Ma J",
        "journal": "Acta neuropathologica communications",
        "last": "Heijnen CJ",
        "pages": "103",
        "volume": "6"
      },
      "evidence": "However, treatment with ACY-1215 in the same schedule that reversed peripheral neuropathy did not restore cognitive function (Fig. 1c) (two-way ANOVA, F (1, 20) = 0.3809, p = 0.54).",
      "key": "c69e7ca3d448634a6e7db419fc9a516c",
      "line": 126,
      "relation": "negativeCorrelation",
      "source": 0,
      "target": 7
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Gender": {
          "Male": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Heijnen CJ",
          "Huo X",
          "Jarpe MB",
          "Kavelaars A",
          "Ma J"
        ],
        "date": "2018-10-01",
        "db": "PubMed",
        "db_id": "30270813",
        "db_name": "Pharmacological inhibition of HDAC6 reverses cognitive impairment and tau pathology as a result of cisplatin treatment.",
        "first": "Ma J",
        "journal": "Acta neuropathologica communications",
        "last": "Heijnen CJ",
        "pages": "103",
        "volume": "6"
      },
      "evidence": "No differences were detected in the total interaction time with objects (two-way ANOVA, F (1, 31) = 0.6425, p = 0.4289) (Fig. 2b), indicating that cisplatin and ACY-1083 had no effect on locomotor activity or interest in the objects..",
      "key": "4645c61d3a13a25921ebefe5f1facd47",
      "line": 135,
      "relation": "causesNoChange",
      "source": 0,
      "target": 5
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Gender": {
          "Male": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Heijnen CJ",
          "Huo X",
          "Jarpe MB",
          "Kavelaars A",
          "Ma J"
        ],
        "date": "2018-10-01",
        "db": "PubMed",
        "db_id": "30270813",
        "db_name": "Pharmacological inhibition of HDAC6 reverses cognitive impairment and tau pathology as a result of cisplatin treatment.",
        "first": "Ma J",
        "journal": "Acta neuropathologica communications",
        "last": "Heijnen CJ",
        "pages": "103",
        "volume": "6"
      },
      "evidence": "Taken together, these findings indicate that cisplatin impaired spatial working memory, executive functioning, and problem-solving abilities in mice and, more importantly, that the brain-penetrating HDAC6 inhibitor ACY-1083 reversed these deficits.",
      "key": "d0719ce221ce44aa3b37eaa770400f6e",
      "line": 147,
      "relation": "decreases",
      "source": 0,
      "target": 20
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Gender": {
          "Male": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Heijnen CJ",
          "Huo X",
          "Jarpe MB",
          "Kavelaars A",
          "Ma J"
        ],
        "date": "2018-10-01",
        "db": "PubMed",
        "db_id": "30270813",
        "db_name": "Pharmacological inhibition of HDAC6 reverses cognitive impairment and tau pathology as a result of cisplatin treatment.",
        "first": "Ma J",
        "journal": "Acta neuropathologica communications",
        "last": "Heijnen CJ",
        "pages": "103",
        "volume": "6"
      },
      "evidence": "Taken together, these findings indicate that cisplatin impaired spatial working memory, executive functioning, and problem-solving abilities in mice and, more importantly, that the brain-penetrating HDAC6 inhibitor ACY-1083 reversed these deficits.",
      "key": "85e530a5f8ec4fa26a057a09634201a9",
      "line": 148,
      "relation": "decreases",
      "source": 0,
      "target": 21
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Gender": {
          "Male": true
        },
        "MeSHAnatomy": {
          "Brain": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Heijnen CJ",
          "Huo X",
          "Jarpe MB",
          "Kavelaars A",
          "Ma J"
        ],
        "date": "2018-10-01",
        "db": "PubMed",
        "db_id": "30270813",
        "db_name": "Pharmacological inhibition of HDAC6 reverses cognitive impairment and tau pathology as a result of cisplatin treatment.",
        "first": "Ma J",
        "journal": "Acta neuropathologica communications",
        "last": "Heijnen CJ",
        "pages": "103",
        "volume": "6"
      },
      "evidence": "Figure 3a shows that cisplatin treatment decreased Î±-tubulin acetylation in the brain (post-hoc test, p = 0.0408) and that this was reversed by ACY-1083 treatment (post-hoc test, p = 0.0170).",
      "key": "a766eb1770c70d6c658f771999c61cb3",
      "line": 163,
      "relation": "decreases",
      "source": 0,
      "target": 15
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Gender": {
          "Male": true
        },
        "MeSHAnatomy": {
          "Brain": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Heijnen CJ",
          "Huo X",
          "Jarpe MB",
          "Kavelaars A",
          "Ma J"
        ],
        "date": "2018-10-01",
        "db": "PubMed",
        "db_id": "30270813",
        "db_name": "Pharmacological inhibition of HDAC6 reverses cognitive impairment and tau pathology as a result of cisplatin treatment.",
        "first": "Ma J",
        "journal": "Acta neuropathologica communications",
        "last": "Heijnen CJ",
        "pages": "103",
        "volume": "6"
      },
      "evidence": "As shown in Fig. 3b, cisplatin did not change the protein level of HDAC6 in the brain (two-way ANOVA, F (1, 12) = 0.7129, p = 0.4150).",
      "key": "f5b4cd7661c5f8883e93dd7240a655b4",
      "line": 172,
      "relation": "causesNoChange",
      "source": 0,
      "target": 10
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Gender": {
          "Male": true
        },
        "MeSHAnatomy": {
          "Synaptosomes": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Heijnen CJ",
          "Huo X",
          "Jarpe MB",
          "Kavelaars A",
          "Ma J"
        ],
        "date": "2018-10-01",
        "db": "PubMed",
        "db_id": "30270813",
        "db_name": "Pharmacological inhibition of HDAC6 reverses cognitive impairment and tau pathology as a result of cisplatin treatment.",
        "first": "Ma J",
        "journal": "Acta neuropathologica communications",
        "last": "Heijnen CJ",
        "pages": "103",
        "volume": "6"
      },
      "evidence": "Figs. 4aâe, cisplatin treatment led to morphological damage to synaptosomal mitochondria, as evidenced by an increased percentage of atypical mitochondria that were swollen and/ or had abnormal cristae structure (post-hoc test, p = 0.0256).",
      "key": "efb802768e7886c1c0ee9b24be4460a2",
      "line": 181,
      "relation": "increases",
      "source": 0,
      "target": 8
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Gender": {
          "Male": true
        },
        "MeSHAnatomy": {
          "Synaptosomes": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Heijnen CJ",
          "Huo X",
          "Jarpe MB",
          "Kavelaars A",
          "Ma J"
        ],
        "date": "2018-10-01",
        "db": "PubMed",
        "db_id": "30270813",
        "db_name": "Pharmacological inhibition of HDAC6 reverses cognitive impairment and tau pathology as a result of cisplatin treatment.",
        "first": "Ma J",
        "journal": "Acta neuropathologica communications",
        "last": "Heijnen CJ",
        "pages": "103",
        "volume": "6"
      },
      "evidence": "Figs. 4aâe, cisplatin treatment led to morphological damage to synaptosomal mitochondria, as evidenced by an increased percentage of atypical mitochondria that were swollen and/ or had abnormal cristae structure (post-hoc test, p = 0.0256).",
      "key": "527bdc4aa19c41a1a7a0406ae76d1dd4",
      "line": 182,
      "relation": "negativeCorrelation",
      "source": 0,
      "target": 4
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Gender": {
          "Male": true
        },
        "MeSHAnatomy": {
          "Synaptosomes": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Heijnen CJ",
          "Huo X",
          "Jarpe MB",
          "Kavelaars A",
          "Ma J"
        ],
        "date": "2018-10-01",
        "db": "PubMed",
        "db_id": "30270813",
        "db_name": "Pharmacological inhibition of HDAC6 reverses cognitive impairment and tau pathology as a result of cisplatin treatment.",
        "first": "Ma J",
        "journal": "Acta neuropathologica communications",
        "last": "Heijnen CJ",
        "pages": "103",
        "volume": "6"
      },
      "evidence": "Furthermore, cisplatin induced significant decreases in parameters measuring synaptosomal mitochondrial bioenergetics, including the maximal respiratory capacity (MRC) (post-hoc test, p = 0.0416) (Fig. 4f ) and spare respiratory capacity (SRC) (post-hoc test, p = 0.0147) (Fig. 4g). ACY-1083 treatment also restored cisplatin-induced impairment in MRC (post-hoc test, p = 0.0345) and SRC (post-hoc test, p = 0.0291) (Fig. 4f and g).",
      "key": "3e1021236288e22a0fbae583031e97b5",
      "line": 208,
      "relation": "decreases",
      "source": 0,
      "target": 19
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Gender": {
          "Male": true
        },
        "MeSHAnatomy": {
          "Synaptosomes": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Heijnen CJ",
          "Huo X",
          "Jarpe MB",
          "Kavelaars A",
          "Ma J"
        ],
        "date": "2018-10-01",
        "db": "PubMed",
        "db_id": "30270813",
        "db_name": "Pharmacological inhibition of HDAC6 reverses cognitive impairment and tau pathology as a result of cisplatin treatment.",
        "first": "Ma J",
        "journal": "Acta neuropathologica communications",
        "last": "Heijnen CJ",
        "pages": "103",
        "volume": "6"
      },
      "evidence": "Furthermore, cisplatin induced significant decreases in parameters measuring synaptosomal mitochondrial bioenergetics, including the maximal respiratory capacity (MRC) (post-hoc test, p = 0.0416) (Fig. 4f ) and spare respiratory capacity (SRC) (post-hoc test, p = 0.0147) (Fig. 4g). ACY-1083 treatment also restored cisplatin-induced impairment in MRC (post-hoc test, p = 0.0345) and SRC (post-hoc test, p = 0.0291) (Fig. 4f and g).",
      "key": "c5510d37f329d815030f798c5f7a1c62",
      "line": 209,
      "relation": "decreases",
      "source": 0,
      "target": 16
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Gender": {
          "Male": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Heijnen CJ",
          "Huo X",
          "Jarpe MB",
          "Kavelaars A",
          "Ma J"
        ],
        "date": "2018-10-01",
        "db": "PubMed",
        "db_id": "30270813",
        "db_name": "Pharmacological inhibition of HDAC6 reverses cognitive impairment and tau pathology as a result of cisplatin treatment.",
        "first": "Ma J",
        "journal": "Acta neuropathologica communications",
        "last": "Heijnen CJ",
        "pages": "103",
        "volume": "6"
      },
      "evidence": "Cisplatin and ACY-1083 did not affect basal respiration (two-way ANOVA, F (1, 20) = 0.6219, p = 0.4396) (Fig. 4h) or ATP-coupled respiration (two-way ANOVA, F (1, 20) = 0.02046, p = 0.8877; n = 6) (Fig. 4i).",
      "key": "d5b7eb4f868a652da8d8fe4955ecf6f0",
      "line": 221,
      "relation": "causesNoChange",
      "source": 0,
      "target": 6
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Gender": {
          "Male": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Heijnen CJ",
          "Huo X",
          "Jarpe MB",
          "Kavelaars A",
          "Ma J"
        ],
        "date": "2018-10-01",
        "db": "PubMed",
        "db_id": "30270813",
        "db_name": "Pharmacological inhibition of HDAC6 reverses cognitive impairment and tau pathology as a result of cisplatin treatment.",
        "first": "Ma J",
        "journal": "Acta neuropathologica communications",
        "last": "Heijnen CJ",
        "pages": "103",
        "volume": "6"
      },
      "evidence": "Cisplatin and ACY-1083 did not affect basal respiration (two-way ANOVA, F (1, 20) = 0.6219, p = 0.4396) (Fig. 4h) or ATP-coupled respiration (two-way ANOVA, F (1, 20) = 0.02046, p = 0.8877; n = 6) (Fig. 4i).",
      "key": "38cd2c9220c1eddf5f2e192193424107",
      "line": 223,
      "relation": "causesNoChange",
      "source": 0,
      "target": 3
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Gender": {
          "Male": true
        },
        "MeSHAnatomy": {
          "CA1 Region, Hippocampal": true,
          "Dentate Gyrus": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Heijnen CJ",
          "Huo X",
          "Jarpe MB",
          "Kavelaars A",
          "Ma J"
        ],
        "date": "2018-10-01",
        "db": "PubMed",
        "db_id": "30270813",
        "db_name": "Pharmacological inhibition of HDAC6 reverses cognitive impairment and tau pathology as a result of cisplatin treatment.",
        "first": "Ma J",
        "journal": "Acta neuropathologica communications",
        "last": "Heijnen CJ",
        "pages": "103",
        "volume": "6"
      },
      "evidence": "The results in Figs. 5 demonstrate that cisplatin reduced the expression of the presynaptic marker synaptophysin (post-hoc, p = 0.0005 for CA1, p < 0.0001 for DG) and the postsynaptic marker PSD95 (post-hoc, p = 0.0138 for CA1, p= 0.0065 for DG) in the CA1 and DG regions of the hippocampus.",
      "key": "9675a10fc300dbe3745ffff45a60efd1",
      "line": 237,
      "relation": "decreases",
      "source": 0,
      "target": 13
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Gender": {
          "Male": true
        },
        "MeSHAnatomy": {
          "CA1 Region, Hippocampal": true,
          "Dentate Gyrus": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Heijnen CJ",
          "Huo X",
          "Jarpe MB",
          "Kavelaars A",
          "Ma J"
        ],
        "date": "2018-10-01",
        "db": "PubMed",
        "db_id": "30270813",
        "db_name": "Pharmacological inhibition of HDAC6 reverses cognitive impairment and tau pathology as a result of cisplatin treatment.",
        "first": "Ma J",
        "journal": "Acta neuropathologica communications",
        "last": "Heijnen CJ",
        "pages": "103",
        "volume": "6"
      },
      "evidence": "The results in Figs. 5 demonstrate that cisplatin reduced the expression of the presynaptic marker synaptophysin (post-hoc, p = 0.0005 for CA1, p < 0.0001 for DG) and the postsynaptic marker PSD95 (post-hoc, p = 0.0138 for CA1, p= 0.0065 for DG) in the CA1 and DG regions of the hippocampus.",
      "key": "468f7f08a7022c872d507d133bb5918a",
      "line": 238,
      "relation": "decreases",
      "source": 0,
      "target": 9
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Gender": {
          "Male": true
        },
        "MeSHAnatomy": {
          "CA1 Region, Hippocampal": true,
          "Dentate Gyrus": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Heijnen CJ",
          "Huo X",
          "Jarpe MB",
          "Kavelaars A",
          "Ma J"
        ],
        "date": "2018-10-01",
        "db": "PubMed",
        "db_id": "30270813",
        "db_name": "Pharmacological inhibition of HDAC6 reverses cognitive impairment and tau pathology as a result of cisplatin treatment.",
        "first": "Ma J",
        "journal": "Acta neuropathologica communications",
        "last": "Heijnen CJ",
        "pages": "103",
        "volume": "6"
      },
      "evidence": "We detected significant upregulation of tau phosphorylation with the AT8 antibody in the CA1 (post-hoc, p = 0.0003) (Figs. 6aâd) and DG (post-hoc, p = 0.0002) (Figs. 6eâh) regions of cisplatin-treated mice.",
      "key": "9efbdcec5ecc0c6feca4a0feaa1b0bc0",
      "line": 258,
      "relation": "increases",
      "source": 0,
      "target": 12
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Gender": {
          "Male": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Heijnen CJ",
          "Huo X",
          "Jarpe MB",
          "Kavelaars A",
          "Ma J"
        ],
        "date": "2018-10-01",
        "db": "PubMed",
        "db_id": "30270813",
        "db_name": "Pharmacological inhibition of HDAC6 reverses cognitive impairment and tau pathology as a result of cisplatin treatment.",
        "first": "Ma J",
        "journal": "Acta neuropathologica communications",
        "last": "Heijnen CJ",
        "pages": "103",
        "volume": "6"
      },
      "evidence": "The cumulative dose of cisplatin has been shown to effectively control tumor growth in mice [47].",
      "key": "2f8e61cd801d63cdc91a0e0ae491a5b9",
      "line": 85,
      "relation": "negativeCorrelation",
      "source": 18,
      "target": 0
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Gender": {
          "Male": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Heijnen CJ",
          "Huo X",
          "Jarpe MB",
          "Kavelaars A",
          "Ma J"
        ],
        "date": "2018-10-01",
        "db": "PubMed",
        "db_id": "30270813",
        "db_name": "Pharmacological inhibition of HDAC6 reverses cognitive impairment and tau pathology as a result of cisplatin treatment.",
        "first": "Ma J",
        "journal": "Acta neuropathologica communications",
        "last": "Heijnen CJ",
        "pages": "103",
        "volume": "6"
      },
      "evidence": "Treatment with 14 doses of the HDAC6 inhibitor ACY-1083 starting 3 days after completion of cisplatin treatment, completely reversed this cognitive deficit (post-hoc test, p = 0.0074) (Fig. 1b).",
      "key": "b126241158416a6c9046a299d288f1d0",
      "line": 104,
      "relation": "increases",
      "source": 2,
      "target": 22
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Gender": {
          "Male": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Heijnen CJ",
          "Huo X",
          "Jarpe MB",
          "Kavelaars A",
          "Ma J"
        ],
        "date": "2018-10-01",
        "db": "PubMed",
        "db_id": "30270813",
        "db_name": "Pharmacological inhibition of HDAC6 reverses cognitive impairment and tau pathology as a result of cisplatin treatment.",
        "first": "Ma J",
        "journal": "Acta neuropathologica communications",
        "last": "Heijnen CJ",
        "pages": "103",
        "volume": "6"
      },
      "evidence": "Taken together, these findings indicate that cisplatin impaired spatial working memory, executive functioning, and problem-solving abilities in mice and, more importantly, that the brain-penetrating HDAC6 inhibitor ACY-1083 reversed these deficits.",
      "key": "cf0dc1f4f67d28cd446fde91b652a119",
      "line": 150,
      "relation": "increases",
      "source": 2,
      "target": 22
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Gender": {
          "Male": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Heijnen CJ",
          "Huo X",
          "Jarpe MB",
          "Kavelaars A",
          "Ma J"
        ],
        "date": "2018-10-01",
        "db": "PubMed",
        "db_id": "30270813",
        "db_name": "Pharmacological inhibition of HDAC6 reverses cognitive impairment and tau pathology as a result of cisplatin treatment.",
        "first": "Ma J",
        "journal": "Acta neuropathologica communications",
        "last": "Heijnen CJ",
        "pages": "103",
        "volume": "6"
      },
      "evidence": "Of note, we showed previously that ACY-1083 and ACY-1215 are equally effective in reversing cisplatin-induced peripheral neuropathy [31].",
      "key": "df1c521dc90138e84769a191ee615c67",
      "line": 115,
      "relation": "decreases",
      "source": 2,
      "target": 17
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Gender": {
          "Male": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Heijnen CJ",
          "Huo X",
          "Jarpe MB",
          "Kavelaars A",
          "Ma J"
        ],
        "date": "2018-10-01",
        "db": "PubMed",
        "db_id": "30270813",
        "db_name": "Pharmacological inhibition of HDAC6 reverses cognitive impairment and tau pathology as a result of cisplatin treatment.",
        "first": "Ma J",
        "journal": "Acta neuropathologica communications",
        "last": "Heijnen CJ",
        "pages": "103",
        "volume": "6"
      },
      "evidence": "No differences were detected in the total interaction time with objects (two-way ANOVA, F (1, 31) = 0.6425, p = 0.4289) (Fig. 2b), indicating that cisplatin and ACY-1083 had no effect on locomotor activity or interest in the objects..",
      "key": "9c2f3ef4dac55be298d40a1dfb6f700f",
      "line": 136,
      "relation": "causesNoChange",
      "source": 2,
      "target": 5
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Gender": {
          "Male": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Heijnen CJ",
          "Huo X",
          "Jarpe MB",
          "Kavelaars A",
          "Ma J"
        ],
        "date": "2018-10-01",
        "db": "PubMed",
        "db_id": "30270813",
        "db_name": "Pharmacological inhibition of HDAC6 reverses cognitive impairment and tau pathology as a result of cisplatin treatment.",
        "first": "Ma J",
        "journal": "Acta neuropathologica communications",
        "last": "Heijnen CJ",
        "pages": "103",
        "volume": "6"
      },
      "evidence": "Taken together, these findings indicate that cisplatin impaired spatial working memory, executive functioning, and problem-solving abilities in mice and, more importantly, that the brain-penetrating HDAC6 inhibitor ACY-1083 reversed these deficits.",
      "key": "c9f6eef801680a2fc5b60401067c3206",
      "line": 149,
      "relation": "decreases",
      "source": 2,
      "target": 10
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Gender": {
          "Male": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Heijnen CJ",
          "Huo X",
          "Jarpe MB",
          "Kavelaars A",
          "Ma J"
        ],
        "date": "2018-10-01",
        "db": "PubMed",
        "db_id": "30270813",
        "db_name": "Pharmacological inhibition of HDAC6 reverses cognitive impairment and tau pathology as a result of cisplatin treatment.",
        "first": "Ma J",
        "journal": "Acta neuropathologica communications",
        "last": "Heijnen CJ",
        "pages": "103",
        "volume": "6"
      },
      "evidence": "Taken together, these findings indicate that cisplatin impaired spatial working memory, executive functioning, and problem-solving abilities in mice and, more importantly, that the brain-penetrating HDAC6 inhibitor ACY-1083 reversed these deficits.",
      "key": "3393e5c9cfbfba491004eaffcd0a63ee",
      "line": 151,
      "relation": "increases",
      "source": 2,
      "target": 20
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Gender": {
          "Male": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Heijnen CJ",
          "Huo X",
          "Jarpe MB",
          "Kavelaars A",
          "Ma J"
        ],
        "date": "2018-10-01",
        "db": "PubMed",
        "db_id": "30270813",
        "db_name": "Pharmacological inhibition of HDAC6 reverses cognitive impairment and tau pathology as a result of cisplatin treatment.",
        "first": "Ma J",
        "journal": "Acta neuropathologica communications",
        "last": "Heijnen CJ",
        "pages": "103",
        "volume": "6"
      },
      "evidence": "Taken together, these findings indicate that cisplatin impaired spatial working memory, executive functioning, and problem-solving abilities in mice and, more importantly, that the brain-penetrating HDAC6 inhibitor ACY-1083 reversed these deficits.",
      "key": "843b8e85f5674decf59a164bda697baa",
      "line": 152,
      "relation": "increases",
      "source": 2,
      "target": 21
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Gender": {
          "Male": true
        },
        "MeSHAnatomy": {
          "Brain": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Heijnen CJ",
          "Huo X",
          "Jarpe MB",
          "Kavelaars A",
          "Ma J"
        ],
        "date": "2018-10-01",
        "db": "PubMed",
        "db_id": "30270813",
        "db_name": "Pharmacological inhibition of HDAC6 reverses cognitive impairment and tau pathology as a result of cisplatin treatment.",
        "first": "Ma J",
        "journal": "Acta neuropathologica communications",
        "last": "Heijnen CJ",
        "pages": "103",
        "volume": "6"
      },
      "evidence": "Figure 3a shows that cisplatin treatment decreased Î±-tubulin acetylation in the brain (post-hoc test, p = 0.0408) and that this was reversed by ACY-1083 treatment (post-hoc test, p = 0.0170).",
      "key": "2c53093c6ede8db43e63039d4d5eb28d",
      "line": 164,
      "relation": "increases",
      "source": 2,
      "target": 15
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Gender": {
          "Male": true
        },
        "MeSHAnatomy": {
          "Synaptosomes": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Heijnen CJ",
          "Huo X",
          "Jarpe MB",
          "Kavelaars A",
          "Ma J"
        ],
        "date": "2018-10-01",
        "db": "PubMed",
        "db_id": "30270813",
        "db_name": "Pharmacological inhibition of HDAC6 reverses cognitive impairment and tau pathology as a result of cisplatin treatment.",
        "first": "Ma J",
        "journal": "Acta neuropathologica communications",
        "last": "Heijnen CJ",
        "pages": "103",
        "volume": "6"
      },
      "evidence": "Notably, these morphological changes were completely reversed by 2 weeks of ACY-1083 treatment (post-hoc test, p = 0.0060)",
      "key": "7433de694e176759c5326e5e4e65a0a2",
      "line": 193,
      "relation": "regulates",
      "source": 2,
      "target": 8
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Gender": {
          "Male": true
        },
        "MeSHAnatomy": {
          "Synaptosomes": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Heijnen CJ",
          "Huo X",
          "Jarpe MB",
          "Kavelaars A",
          "Ma J"
        ],
        "date": "2018-10-01",
        "db": "PubMed",
        "db_id": "30270813",
        "db_name": "Pharmacological inhibition of HDAC6 reverses cognitive impairment and tau pathology as a result of cisplatin treatment.",
        "first": "Ma J",
        "journal": "Acta neuropathologica communications",
        "last": "Heijnen CJ",
        "pages": "103",
        "volume": "6"
      },
      "evidence": "Notably, these morphological changes were completely reversed by 2 weeks of ACY-1083 treatment (post-hoc test, p = 0.0060)",
      "key": "d5c0b0661ec85b1faf58ecbdefbbd6d6",
      "line": 194,
      "relation": "positiveCorrelation",
      "source": 2,
      "target": 4
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Gender": {
          "Male": true
        },
        "MeSHAnatomy": {
          "Synaptosomes": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Heijnen CJ",
          "Huo X",
          "Jarpe MB",
          "Kavelaars A",
          "Ma J"
        ],
        "date": "2018-10-01",
        "db": "PubMed",
        "db_id": "30270813",
        "db_name": "Pharmacological inhibition of HDAC6 reverses cognitive impairment and tau pathology as a result of cisplatin treatment.",
        "first": "Ma J",
        "journal": "Acta neuropathologica communications",
        "last": "Heijnen CJ",
        "pages": "103",
        "volume": "6"
      },
      "evidence": "Furthermore, cisplatin induced significant decreases in parameters measuring synaptosomal mitochondrial bioenergetics, including the maximal respiratory capacity (MRC) (post-hoc test, p = 0.0416) (Fig. 4f ) and spare respiratory capacity (SRC) (post-hoc test, p = 0.0147) (Fig. 4g). ACY-1083 treatment also restored cisplatin-induced impairment in MRC (post-hoc test, p = 0.0345) and SRC (post-hoc test, p = 0.0291) (Fig. 4f and g).",
      "key": "4cff149a873b45fe729ccc354b0b13eb",
      "line": 210,
      "relation": "increases",
      "source": 2,
      "target": 19
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Gender": {
          "Male": true
        },
        "MeSHAnatomy": {
          "Synaptosomes": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Heijnen CJ",
          "Huo X",
          "Jarpe MB",
          "Kavelaars A",
          "Ma J"
        ],
        "date": "2018-10-01",
        "db": "PubMed",
        "db_id": "30270813",
        "db_name": "Pharmacological inhibition of HDAC6 reverses cognitive impairment and tau pathology as a result of cisplatin treatment.",
        "first": "Ma J",
        "journal": "Acta neuropathologica communications",
        "last": "Heijnen CJ",
        "pages": "103",
        "volume": "6"
      },
      "evidence": "Furthermore, cisplatin induced significant decreases in parameters measuring synaptosomal mitochondrial bioenergetics, including the maximal respiratory capacity (MRC) (post-hoc test, p = 0.0416) (Fig. 4f ) and spare respiratory capacity (SRC) (post-hoc test, p = 0.0147) (Fig. 4g). ACY-1083 treatment also restored cisplatin-induced impairment in MRC (post-hoc test, p = 0.0345) and SRC (post-hoc test, p = 0.0291) (Fig. 4f and g).",
      "key": "497f8eff4d167e93ce9a31fcd49e9a2a",
      "line": 211,
      "relation": "increases",
      "source": 2,
      "target": 16
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Gender": {
          "Male": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Heijnen CJ",
          "Huo X",
          "Jarpe MB",
          "Kavelaars A",
          "Ma J"
        ],
        "date": "2018-10-01",
        "db": "PubMed",
        "db_id": "30270813",
        "db_name": "Pharmacological inhibition of HDAC6 reverses cognitive impairment and tau pathology as a result of cisplatin treatment.",
        "first": "Ma J",
        "journal": "Acta neuropathologica communications",
        "last": "Heijnen CJ",
        "pages": "103",
        "volume": "6"
      },
      "evidence": "Cisplatin and ACY-1083 did not affect basal respiration (two-way ANOVA, F (1, 20) = 0.6219, p = 0.4396) (Fig. 4h) or ATP-coupled respiration (two-way ANOVA, F (1, 20) = 0.02046, p = 0.8877; n = 6) (Fig. 4i).",
      "key": "7a5acba1114556d574a3679fd6e9325e",
      "line": 222,
      "relation": "causesNoChange",
      "source": 2,
      "target": 6
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Gender": {
          "Male": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Heijnen CJ",
          "Huo X",
          "Jarpe MB",
          "Kavelaars A",
          "Ma J"
        ],
        "date": "2018-10-01",
        "db": "PubMed",
        "db_id": "30270813",
        "db_name": "Pharmacological inhibition of HDAC6 reverses cognitive impairment and tau pathology as a result of cisplatin treatment.",
        "first": "Ma J",
        "journal": "Acta neuropathologica communications",
        "last": "Heijnen CJ",
        "pages": "103",
        "volume": "6"
      },
      "evidence": "Cisplatin and ACY-1083 did not affect basal respiration (two-way ANOVA, F (1, 20) = 0.6219, p = 0.4396) (Fig. 4h) or ATP-coupled respiration (two-way ANOVA, F (1, 20) = 0.02046, p = 0.8877; n = 6) (Fig. 4i).",
      "key": "445dc2b32e302a918019ce6cb5c2a106",
      "line": 224,
      "relation": "causesNoChange",
      "source": 2,
      "target": 3
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Gender": {
          "Male": true
        },
        "MeSHAnatomy": {
          "CA1 Region, Hippocampal": true,
          "Dentate Gyrus": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Heijnen CJ",
          "Huo X",
          "Jarpe MB",
          "Kavelaars A",
          "Ma J"
        ],
        "date": "2018-10-01",
        "db": "PubMed",
        "db_id": "30270813",
        "db_name": "Pharmacological inhibition of HDAC6 reverses cognitive impairment and tau pathology as a result of cisplatin treatment.",
        "first": "Ma J",
        "journal": "Acta neuropathologica communications",
        "last": "Heijnen CJ",
        "pages": "103",
        "volume": "6"
      },
      "evidence": "Two weeks of ACY-1083 treatment normalized expression of both the presynaptic (post-hoc, p < 0.0001 for CA1, p < 0.0001 for DG) and postsynaptic markers (post-hoc, p = 0.0434 for CA1, p= 0.0275 for DG).",
      "key": "2ab70d15ad798d91be904e9e2c3caa2b",
      "line": 248,
      "relation": "increases",
      "source": 2,
      "target": 13
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Gender": {
          "Male": true
        },
        "MeSHAnatomy": {
          "CA1 Region, Hippocampal": true,
          "Dentate Gyrus": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Heijnen CJ",
          "Huo X",
          "Jarpe MB",
          "Kavelaars A",
          "Ma J"
        ],
        "date": "2018-10-01",
        "db": "PubMed",
        "db_id": "30270813",
        "db_name": "Pharmacological inhibition of HDAC6 reverses cognitive impairment and tau pathology as a result of cisplatin treatment.",
        "first": "Ma J",
        "journal": "Acta neuropathologica communications",
        "last": "Heijnen CJ",
        "pages": "103",
        "volume": "6"
      },
      "evidence": "Two weeks of ACY-1083 treatment normalized expression of both the presynaptic (post-hoc, p < 0.0001 for CA1, p < 0.0001 for DG) and postsynaptic markers (post-hoc, p = 0.0434 for CA1, p= 0.0275 for DG).",
      "key": "34a320db8c82ca6b2e59665e82e48d9c",
      "line": 249,
      "relation": "increases",
      "source": 2,
      "target": 9
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Gender": {
          "Male": true
        },
        "MeSHAnatomy": {
          "CA1 Region, Hippocampal": true,
          "Dentate Gyrus": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Heijnen CJ",
          "Huo X",
          "Jarpe MB",
          "Kavelaars A",
          "Ma J"
        ],
        "date": "2018-10-01",
        "db": "PubMed",
        "db_id": "30270813",
        "db_name": "Pharmacological inhibition of HDAC6 reverses cognitive impairment and tau pathology as a result of cisplatin treatment.",
        "first": "Ma J",
        "journal": "Acta neuropathologica communications",
        "last": "Heijnen CJ",
        "pages": "103",
        "volume": "6"
      },
      "evidence": "Notably, ACY-1083 treatment completely reversed tau hyperphosphorylation induced by cisplatin treatment (post-hoc, p = 0.0002 for CA1, p = 0.0013 for DG) (Fig. 6i and j).",
      "key": "b4722a656485474b4141feedc4a90287",
      "line": 266,
      "relation": "decreases",
      "source": 2,
      "target": 12
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Gender": {
          "Male": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Heijnen CJ",
          "Huo X",
          "Jarpe MB",
          "Kavelaars A",
          "Ma J"
        ],
        "date": "2018-10-01",
        "db": "PubMed",
        "db_id": "30270813",
        "db_name": "Pharmacological inhibition of HDAC6 reverses cognitive impairment and tau pathology as a result of cisplatin treatment.",
        "first": "Ma J",
        "journal": "Acta neuropathologica communications",
        "last": "Heijnen CJ",
        "pages": "103",
        "volume": "6"
      },
      "evidence": "Of note, we showed previously that ACY-1083 and ACY-1215 are equally effective in reversing cisplatin-induced peripheral neuropathy [31].",
      "key": "2b6cdfa0221e8a9f34a567be8499bc0a",
      "line": 116,
      "relation": "decreases",
      "source": 1,
      "target": 17
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Gender": {
          "Male": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Heijnen CJ",
          "Huo X",
          "Jarpe MB",
          "Kavelaars A",
          "Ma J"
        ],
        "date": "2018-10-01",
        "db": "PubMed",
        "db_id": "30270813",
        "db_name": "Pharmacological inhibition of HDAC6 reverses cognitive impairment and tau pathology as a result of cisplatin treatment.",
        "first": "Ma J",
        "journal": "Acta neuropathologica communications",
        "last": "Heijnen CJ",
        "pages": "103",
        "volume": "6"
      },
      "evidence": "However, treatment with ACY-1215 in the same schedule that reversed peripheral neuropathy did not restore cognitive function (Fig. 1c) (two-way ANOVA, F (1, 20) = 0.3809, p = 0.54).",
      "key": "43dcefff72519aba113e2b4ea2292533",
      "line": 125,
      "relation": "causesNoChange",
      "source": 1,
      "target": 7
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Gender": {
          "Male": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Heijnen CJ",
          "Huo X",
          "Jarpe MB",
          "Kavelaars A",
          "Ma J"
        ],
        "date": "2018-10-01",
        "db": "PubMed",
        "db_id": "30270813",
        "db_name": "Pharmacological inhibition of HDAC6 reverses cognitive impairment and tau pathology as a result of cisplatin treatment.",
        "first": "Ma J",
        "journal": "Acta neuropathologica communications",
        "last": "Heijnen CJ",
        "pages": "103",
        "volume": "6"
      },
      "evidence": "However, treatment with ACY-1215 in the same schedule that reversed peripheral neuropathy did not restore cognitive function (Fig. 1c) (two-way ANOVA, F (1, 20) = 0.3809, p = 0.54).",
      "key": "d752bf4a43c0fae32124929309856fd1",
      "line": 126,
      "relation": "negativeCorrelation",
      "source": 7,
      "target": 0
    },
    {
      "key": "5e62edb6575e6807b74e052fb9ef4439",
      "relation": "hasVariant",
      "source": 14,
      "target": 15
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Gender": {
          "Male": true
        },
        "MeSHAnatomy": {
          "Synaptosomes": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Heijnen CJ",
          "Huo X",
          "Jarpe MB",
          "Kavelaars A",
          "Ma J"
        ],
        "date": "2018-10-01",
        "db": "PubMed",
        "db_id": "30270813",
        "db_name": "Pharmacological inhibition of HDAC6 reverses cognitive impairment and tau pathology as a result of cisplatin treatment.",
        "first": "Ma J",
        "journal": "Acta neuropathologica communications",
        "last": "Heijnen CJ",
        "pages": "103",
        "volume": "6"
      },
      "evidence": "Figs. 4aâe, cisplatin treatment led to morphological damage to synaptosomal mitochondria, as evidenced by an increased percentage of atypical mitochondria that were swollen and/ or had abnormal cristae structure (post-hoc test, p = 0.0256).",
      "key": "34de7d378bcd08087cc77bcdf70d726a",
      "line": 182,
      "relation": "negativeCorrelation",
      "source": 4,
      "target": 0
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Gender": {
          "Male": true
        },
        "MeSHAnatomy": {
          "Synaptosomes": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Heijnen CJ",
          "Huo X",
          "Jarpe MB",
          "Kavelaars A",
          "Ma J"
        ],
        "date": "2018-10-01",
        "db": "PubMed",
        "db_id": "30270813",
        "db_name": "Pharmacological inhibition of HDAC6 reverses cognitive impairment and tau pathology as a result of cisplatin treatment.",
        "first": "Ma J",
        "journal": "Acta neuropathologica communications",
        "last": "Heijnen CJ",
        "pages": "103",
        "volume": "6"
      },
      "evidence": "Notably, these morphological changes were completely reversed by 2 weeks of ACY-1083 treatment (post-hoc test, p = 0.0060)",
      "key": "0cb581ed15d12f2d5ffced52d15b7e69",
      "line": 194,
      "relation": "positiveCorrelation",
      "source": 4,
      "target": 2
    },
    {
      "key": "064f60bbd4e86ec0d71e89e733af2e71",
      "relation": "hasVariant",
      "source": 11,
      "target": 12
    }
  ],
  "multigraph": true,
  "nodes": [
    {
      "bel": "a(CHEBI:cisplatin)",
      "concept": {
        "name": "cisplatin",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "c5ae2d0842cc71cd56eab17ff8638bf9"
    },
    {
      "bel": "a(PUBCHEM:53340666)",
      "concept": {
        "name": "53340666",
        "namespace": "PUBCHEM"
      },
      "function": "Abundance",
      "id": "e6ef205ddc0f44f5c05a490db98b7877"
    },
    {
      "bel": "a(PUBCHEM:91844718)",
      "concept": {
        "name": "91844718",
        "namespace": "PUBCHEM"
      },
      "function": "Abundance",
      "id": "8e0833f3ee7b7173cf68eb67e483147c"
    },
    {
      "bel": "bp(GO:\"cellular respiration\")",
      "concept": {
        "name": "cellular respiration",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "ced509226a10b89fb0f158c6a90c60c2"
    },
    {
      "bel": "bp(GO:\"cristae formation\")",
      "concept": {
        "name": "cristae formation",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "5dcac5ceb713375dc667085af2d5019c"
    },
    {
      "bel": "bp(GO:\"locomotory behavior\")",
      "concept": {
        "name": "locomotory behavior",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "a907c571bb81593a8ebc7e0ebcbc2401"
    },
    {
      "bel": "bp(GO:\"respiratory gaseous exchange by respiratory system\")",
      "concept": {
        "name": "respiratory gaseous exchange by respiratory system",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "2303ff86236c48afd8f87392104d462d"
    },
    {
      "bel": "bp(GO:cognition)",
      "concept": {
        "name": "cognition",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "24220ec2073c35bcd945681ee9c6ea38"
    },
    {
      "bel": "bp(MESH:\"Mitochondrial Size\")",
      "concept": {
        "name": "Mitochondrial Size",
        "namespace": "MESH"
      },
      "function": "BiologicalProcess",
      "id": "e5e0045a441d54c07400f9200271dc25"
    },
    {
      "bel": "p(HGNC:DLG4)",
      "concept": {
        "name": "DLG4",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "082b74394486030c137352b1d3f26b92"
    },
    {
      "bel": "p(HGNC:HDAC6)",
      "concept": {
        "name": "HDAC6",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "8f10ead99d8970092c3980eb37bcfb3a"
    },
    {
      "bel": "p(HGNC:MAPT)",
      "concept": {
        "name": "MAPT",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "7d1009217050e75d549c8c5aa83309a8"
    },
    {
      "bel": "p(HGNC:MAPT, pmod(Ph))",
      "concept": {
        "name": "MAPT",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "a8fb3a87d5a0672c07462bb17c8b0947",
      "variants": [
        {
          "concept": {
            "name": "Ph",
            "namespace": "bel"
          },
          "kind": "pmod"
        }
      ]
    },
    {
      "bel": "p(HGNC:SYP)",
      "concept": {
        "name": "SYP",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "626a2f555ceb0470e910c27522d5b97c"
    },
    {
      "bel": "p(INTERPRO:\"Alpha tubulin\")",
      "concept": {
        "name": "Alpha tubulin",
        "namespace": "INTERPRO"
      },
      "function": "Protein",
      "id": "2b4985733912e25a1c639112bb278eef"
    },
    {
      "bel": "p(INTERPRO:\"Alpha tubulin\", pmod(Ac))",
      "concept": {
        "name": "Alpha tubulin",
        "namespace": "INTERPRO"
      },
      "function": "Protein",
      "id": "446d9f3763ca55de80d3e407e35199ac",
      "variants": [
        {
          "concept": {
            "name": "Ac",
            "namespace": "bel"
          },
          "kind": "pmod"
        }
      ]
    },
    {
      "bel": "path(EFO:\"maximal oxygen uptake measurement\")",
      "concept": {
        "name": "maximal oxygen uptake measurement",
        "namespace": "EFO"
      },
      "function": "Pathology",
      "id": "02fe81678319ccacb6924e00a43d0493"
    },
    {
      "bel": "path(EFO:\"peripheral neuropathy\")",
      "concept": {
        "name": "peripheral neuropathy",
        "namespace": "EFO"
      },
      "function": "Pathology",
      "id": "073025e1cb3f021fa616912776a3ca45"
    },
    {
      "bel": "path(EFO:neoplasm)",
      "concept": {
        "name": "neoplasm",
        "namespace": "EFO"
      },
      "function": "Pathology",
      "id": "4b4402a88dd9ec5e0e5d3b321ce74567"
    },
    {
      "bel": "path(MESH:\"Energy Metabolism\")",
      "concept": {
        "name": "Energy Metabolism",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "266b2ade166522498effb10b3b6890c9"
    },
    {
      "bel": "path(MESH:\"Executive Function\")",
      "concept": {
        "name": "Executive Function",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "cf426453e61e2674d5e1e153c4463cd3"
    },
    {
      "bel": "path(MESH:\"Problem Solving\")",
      "concept": {
        "name": "Problem Solving",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "b1dcece6845c80b21c4b6c9164550663"
    },
    {
      "bel": "path(MESH:\"Spatial Memory\")",
      "concept": {
        "name": "Spatial Memory",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "6689b53b9c19fb722f9715d6f4df2ecc"
    }
  ]
}